Bladder Cancer
Showing NaN - NaN of 115
Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)
Completed
- Bladder Cancer
- Urothelial Carcinoma
-
Birmingham, Alabama
- +34 more
Jul 7, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Bladder Cancer, Melanoma Trial in United States (Nivolumab, Nivolumab plus Ipilimumab)
Active, not recruiting
- Bladder Cancer
- Melanoma
- Nivolumab
- Nivolumab plus Ipilimumab
-
Farmington, Connecticut
- +4 more
May 9, 2022
Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)
Bladder Cancer Recurrence Study (The DETER Study)
Active, not recruiting
- Bladder Cancer
- questionnaires
- Saliva and/or urine sample
-
Basking Ridge, New Jersey
- +3 more
Apr 11, 2022
Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)
Recruiting
- Breast Cancer
- +6 more
- PCR/PCR/LDR Strategy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 1, 2022
Bladder Cancer Trial in United States (external radiation therapy with gemcitabine)
Active, not recruiting
- Bladder Cancer
- external radiation therapy with gemcitabine
-
Basking Ridge, New Jersey
- +4 more
Mar 9, 2022
Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)
Completed
- Head and Neck Squamous Cell Carcinoma
- +10 more
- Durvalumab
- +2 more
-
Atlanta, Georgia
- +6 more
Mar 1, 2022
Solid Tumor Cancers, Lung Cancer, Bladder Cancer Trial in United States (ado-trastuzumab emtansine)
Recruiting
- Solid Tumor Cancers
- +3 more
- ado-trastuzumab emtansine
-
Basking Ridge, New Jersey
- +6 more
Mar 1, 2022
Bladder Cancer, High Risk Superficial Trial in United States (Bacillus Calmette-Guérin (BCG))
Completed
- Bladder Cancer
- High Risk Superficial
- Bacillus Calmette-Guérin (BCG)
-
Basking Ridge, New Jersey
- +4 more
Feb 28, 2022
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Bladder Cancer, Non-Muscle-Invasive Urothelial Carcinoma Trial in New York (BGJ398)
Active, not recruiting
- Bladder Cancer
- Non-Muscle-Invasive Urothelial Carcinoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 3, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)
Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 16, 2021
Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce
Completed
- Bladder Cancer
- +8 more
- NanoDoce (direct injection)
- +3 more
-
Phoenix, Arizona
- +4 more
Nov 29, 2021
Bladder Cancer, Complications Trial in New York (Clear liquid diet)
Completed
- Bladder Cancer
- Complications
- Clear liquid diet
-
New York, New York
- +1 more
Aug 13, 2021
Bladder Cancer Trial in Canada, United States (Vicinium)
Active, not recruiting
- Bladder Cancer
- Vicinium
-
Birmingham, Alabama
- +69 more
Jun 10, 2021